name,category,termsEPH receptor A10,INTERPRO[450000618$IPR000719:Protein kinase, core, 450000955$IPR001090:Ephrin receptor, ligand binding, 450001096$IPR001245:Tyrosine protein kinase, 450001270$IPR001426:Receptor tyrosine kinase, class V, conserved site, 450001470$IPR001660:Sterile alpha motif SAM, 450003484$IPR003961:Fibronectin, type III, 450007559$IPR008266:Tyrosine protein kinase, active site, 450008173$IPR008957:Fibronectin, type III-like fold, 450011699$IPR013032:EGF-like region, conserved site, 450012380$IPR013761:Sterile alpha motif-type, 450014581$IPR016257:Tyrosine-protein kinase, ephrin receptor, 450015769$IPR017441:Protein kinase, ATP binding site]
EPH receptor A10,PIR_SUPERFAMILY[630000779$PIRSF000666:tyrosine-protein kinase, ephrin receptor type, 630000780$PIRSF000666:TyrPK_ephrin_receptor]
EPH receptor A10,SMART[760000051$SM00060:FN3, 760000192$SM00219:TyrKc, 760000399$SM00454:SAM, 760000544$SM00615:EPH_lbd]
EPH receptor A10,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000264$cell membrane, 790000356$complete proteome, 790000616$glycoprotein, 790000825$kinase, 790000919$membrane, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001547$transferase, 790001555$transmembrane, 790001586$tyrosine-protein kinase]
EPH receptor A10,UP_SEQ_FEATURE[850017609$chain:Ephrin type-A receptor 10, 850103800$domain:Fibronectin type-III 1, 850103849$domain:Fibronectin type-III 2, 850105086$domain:Protein kinase, 850105249$domain:SAM, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
G protein-coupled receptor 141,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
G protein-coupled receptor 141,PIR_SUPERFAMILY[630030103$PIRSF038599:probable G protein-coupled receptor 141, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
G protein-coupled receptor 141,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001301$receptor, 790001546$transducer, 790001555$transmembrane]
G protein-coupled receptor 141,UP_SEQ_FEATURE[850042041$chain:Probable G-protein coupled receptor 141, 850105770$glycosylation site:N-linked (GlcNAc...), 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
HOP homeobox,BIOCARTA[30000140$h_hopPathway:Hop Pathway in Cardiac Development]
HOP homeobox,INTERPRO[450001200$IPR001356:Homeobox, 450010997$IPR012287:Homeodomain-related, 450016278$IPR017970:Homeobox, conserved site]
HOP homeobox,SMART[760000341$SM00389:HOX]
HOP homeobox,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000428$developmental protein, 790000699$Homeobox, 790001065$nucleus, 790001271$Proto-oncogene, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
HOP homeobox,UP_SEQ_FEATURE[850024782$chain:Homeodomain-only protein, 850102933$DNA-binding region:Homeobox; atypical, 850117294$sequence conflict, 850118574$splice variant]
NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa,INTERPRO[450001725$IPR001949:NADH:ubiquinone oxidoreductase, 51 kDa subunit, conserved site, 450010398$IPR011537:NADH ubiquinone oxidoreductase, F subunit, 450010399$IPR011538:NADH:ubiquinone oxidoreductase, 51 kDa subunit, 450017791$IPR019554:Soluble ligand binding domain, 450017812$IPR019575:NADH ubiquinone oxidoreductase, F subunit, iron sulphur binding]
NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa,KEGG_PATHWAY[470038741$hsa00190:Oxidative phosphorylation, 470038891$hsa05010:Alzheimer's disease, 470038892$hsa05012:Parkinson's disease, 470038894$hsa05016:Huntington's disease]
NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa,OMIM_DISEASE[520000214$Alexander disease, 520002806$Leigh syndrome, 520003336$Mitochondrial complex I deficiency]
NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa,PIR_SUPERFAMILY[630000261$PIRSF000217:NADH-ubiquinone oxidoreductase, 51 kDa subunit]
NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa,SP_PIR_KEYWORDS[790000005$4fe-4s, 790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000446$disease mutation, 790000489$electron transport, 790000559$Flavoprotein, 790000562$fmn, 790000802$iron, 790000806$iron-sulfur, 790000807$iron-sulfur protein, 790000849$leigh syndrome, 790000919$membrane, 790000926$membrane-associated complex, 790000937$metal-binding, 790000943$metalloprotein, 790000966$mitochondrial inner membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001006$nad, 790001091$oxidative phosphorylation, 790001092$oxidoreductase, 790001212$polymorphism, 790001309$respiratory chain, 790001550$transit peptide, 790001558$transport, 790001589$ubiquinone]
NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa,UP_SEQ_FEATURE[850033543$chain:NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial, 850106068$metal ion-binding site:Iron-sulfur (4Fe-4S), 850106258$modified residue, 850106292$nucleotide phosphate-binding region:FMN, 850106304$nucleotide phosphate-binding region:NAD(H), 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118617$transit peptide:Mitochondrion]
Rho/Rac guanine nucleotide exchange factor (GEF) 18,INTERPRO[450000189$IPR000219:Dbl homology (DH) domain, 450001173$IPR001331:Guanine-nucleotide dissociation stimulator, CDC24, conserved site, 450001635$IPR001849:Pleckstrin homology, 450010818$IPR011993:Pleckstrin homology-type, 450014156$IPR015721:Rho GTP exchange factor]
Rho/Rac guanine nucleotide exchange factor (GEF) 18,SMART[760000205$SM00233:PH, 760000294$SM00325:RhoGEF]
Rho/Rac guanine nucleotide exchange factor (GEF) 18,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000641$guanine-nucleotide releasing factor, 790001162$phosphoprotein, 790001212$polymorphism]
Rho/Rac guanine nucleotide exchange factor (GEF) 18,UP_SEQ_FEATURE[850057570$chain:Rho guanine nucleotide exchange factor 18, 850102586$compositionally biased region:Pro-rich, 850103518$domain:DH, 850104979$domain:PH, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
SRY (sex determining region Y)-box 12,INTERPRO[450000793$IPR000910:High mobility group, HMG1/HMG2, 450015712$IPR017386:SOX-12/11/4a]
SRY (sex determining region Y)-box 12,PIR_SUPERFAMILY[630029685$PIRSF038098:SOX-12/11/4a, 630029686$PIRSF038098:SOX-12/11/4a protein]
SRY (sex determining region Y)-box 12,SMART[760000349$SM00398:HMG]
SRY (sex determining region Y)-box 12,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001539$Transcription, 790001543$transcription regulation]
SRY (sex determining region Y)-box 12,UP_SEQ_FEATURE[850065308$chain:Transcription factor SOX-12, 850102464$compositionally biased region:Asp/Glu-rich (acidic), 850102565$compositionally biased region:Poly-Ala, 850102572$compositionally biased region:Poly-Glu, 850102580$compositionally biased region:Poly-Pro, 850102920$DNA-binding region:HMG box]
T-cell leukemia/lymphoma 1B,INTERPRO[450004312$IPR004832:TCL1/MTCP1]
T-cell leukemia/lymphoma 1B,OMIM_DISEASE[520002874$Leukemia/lymphoma, T-cell]
T-cell leukemia/lymphoma 1B,SP_PIR_KEYWORDS[790000316$chromosomal rearrangement, 790000356$complete proteome, 790001212$polymorphism, 790001271$Proto-oncogene]
T-cell leukemia/lymphoma 1B,UP_SEQ_FEATURE[850063367$chain:T-cell leukemia/lymphoma protein 1B, 850117295$sequence variant]
arylacetamide deacetylase-like 4,INTERPRO[450001923$IPR002168:Lipase, GDXG, active site, 450011738$IPR013094:Alpha/beta hydrolase fold-3, 450015477$IPR017157:Arylacetamide deacetylase]
arylacetamide deacetylase-like 4,PIR_SUPERFAMILY[630028788$PIRSF037251:arylacetamide deacetylase, 630028789$PIRSF037251:Arylacetamide_deacetylase]
arylacetamide deacetylase-like 4,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000743$hydrolase, 790000919$membrane, 790001409$Signal-anchor, 790001555$transmembrane]
arylacetamide deacetylase-like 4,UP_SEQ_FEATURE[850006202$chain:Arylacetamide deacetylase-like 4, 850105770$glycosylation site:N-linked (GlcNAc...), 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
chromosome 15 open reading frame 26,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
chromosome 15 open reading frame 26,UP_SEQ_FEATURE[850073217$chain:Uncharacterized protein C15orf26, 850117295$sequence variant, 850118574$splice variant]
chromosome 4 open reading frame 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
chromosome 4 open reading frame 3,UP_SEQ_FEATURE[850074182$chain:Uncharacterized protein C4orf3, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
chromosome 6 open reading frame 10,OMIM_DISEASE[520003402$Multiple Genetic Loci for Bone Mineral Density and Fractures]
chromosome 6 open reading frame 10,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane]
chromosome 6 open reading frame 10,UP_SEQ_FEATURE[850074323$chain:Uncharacterized protein C6orf10, 850102554$compositionally biased region:Lys-rich, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
chromosome 7 open reading frame 50,INTERPRO[450017565$IPR019327:Protein of unknown function DUF2373]
chromosome 7 open reading frame 50,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein]
chromosome 7 open reading frame 50,UP_SEQ_FEATURE[850074428$chain:Uncharacterized protein C7orf50, 850106258$modified residue]
chromosome X open reading frame 23,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000969$mitochondrion, 790001162$phosphoprotein]
chromosome X open reading frame 23,UP_SEQ_FEATURE[850074704$chain:Uncharacterized protein CXorf23, 850106258$modified residue, 850118574$splice variant]
complement factor H,INTERPRO[450000373$IPR000436:Sushi/SCR/CCP, 450014444$IPR016060:Complement control module]
complement factor H,KEGG_PATHWAY[470038859$hsa04610:Complement and coagulation cascades]
complement factor H,OMIM_DISEASE[520000540$Basal laminar drusen, 520001139$Complement factor H deficiency, 520001140$Complement factor H polymorphism in age-related macular degeneration, 520001846$Factor H and factor H-like 1, 520002270$Hemolytic-uremic syndrome, 520003013$Macular degeneration, age-related, 4, 520003138$Membranoproliferative glomerulonephritis with CFH deficiency, 520003478$Myocardial infarction, susceptibility to]
complement factor H,PIR_SUPERFAMILY[630002598$PIRSF002482:complement factor H]
complement factor H,SMART[760000024$SM00032:CCP]
complement factor H,SP_PIR_KEYWORDS[790000002$3d-structure, 790000032$age-related macular degeneration, 790000053$alternative splicing, 790000352$complement alternate pathway, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000447$disulfide bond, 790000616$glycoprotein, 790000763$immune response, 790000777$innate immunity, 790001212$polymorphism, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001471$sushi]
complement factor H,UP_SEQ_FEATURE[850012386$chain:Complement factor H, 850102883$disulfide bond, 850105416$domain:Sushi 1, 850105417$domain:Sushi 10, 850105418$domain:Sushi 11, 850105419$domain:Sushi 12, 850105420$domain:Sushi 13, 850105421$domain:Sushi 14, 850105422$domain:Sushi 15, 850105423$domain:Sushi 16, 850105424$domain:Sushi 17, 850105425$domain:Sushi 18, 850105426$domain:Sushi 19, 850105429$domain:Sushi 2, 850105430$domain:Sushi 20, 850105440$domain:Sushi 3, 850105446$domain:Sushi 4, 850105447$domain:Sushi 5, 850105448$domain:Sushi 6, 850105449$domain:Sushi 7, 850105450$domain:Sushi 8, 850105451$domain:Sushi 9, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118450$site:Not glycosylated, 850118574$splice variant, 850118575$strand, 850118624$turn]
geminin, DNA replication inhibitor,INTERPRO[450009069$IPR009984:Geminin]
geminin, DNA replication inhibitor,PIR_SUPERFAMILY[630030014$PIRSF038488:Geminin]
geminin, DNA replication inhibitor,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000258$cell cycle, 790000344$coiled coil, 790000356$complete proteome, 790000461$dna replication inhibitor, 790001162$phosphoprotein, 790001212$polymorphism]
geminin, DNA replication inhibitor,UP_SEQ_FEATURE[850020875$chain:Geminin, 850105852$helix, 850106258$modified residue, 850117295$sequence variant]
glycoprotein Ib (platelet), alpha polypeptide,COG_ONTOLOGY[90000070$Function unknown]
glycoprotein Ib (platelet), alpha polypeptide,INTERPRO[450000318$IPR000372:Leucine-rich repeat, cysteine-rich flanking region, N-terminal, 450000409$IPR000483:Cysteine-rich flanking region, C-terminal, 450001429$IPR001611:Leucine-rich repeat, 450003153$IPR003591:Leucine-rich repeat, typical subtype]
glycoprotein Ib (platelet), alpha polypeptide,KEGG_PATHWAY[470038854$hsa04512:ECM-receptor interaction, 470038867$hsa04640:Hematopoietic cell lineage]
glycoprotein Ib (platelet), alpha polypeptide,OMIM_DISEASE[520000552$Bernard-Soulier syndrome, benign autosomal dominant, 520000553$Bernard-Soulier syndrome, type A, 520003672$Nonarteritic anterior ischemic optic neuropathy, susceptibility to, 520005056$von Willebrand disease, platelet-type]
glycoprotein Ib (platelet), alpha polypeptide,PIR_SUPERFAMILY[630002611$PIRSF002493:platelet glycoprotein Ib alpha chain]
glycoprotein Ib (platelet), alpha polypeptide,SMART[760000007$SM00013:LRRNT, 760000071$SM00082:LRRCT, 760000333$SM00369:LRR_TYP]
glycoprotein Ib (platelet), alpha polypeptide,SP_PIR_KEYWORDS[790000002$3d-structure, 790000175$bernard soulier syndrome, 790000192$blood coagulation, 790000256$cell adhesion, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000447$disulfide bond, 790000473$duplication, 790000616$glycoprotein, 790000666$hemostasis, 790000853$leucine-rich repeat, 790000919$membrane, 790001162$phosphoprotein, 790001207$platelet membrane, 790001212$polymorphism, 790001304$repeat, 790001405$signal, 790001461$sulfation, 790001484$tandem repeat, 790001517$thrombin binding, 790001555$transmembrane, 790001556$transmembrane protein, 790001634$von Willebrand disease, 790001635$von Willebrand factor binding]
glycoprotein Ib (platelet), alpha polypeptide,UP_SEQ_FEATURE[850022037$chain:Glycocalicin, 850039522$chain:Platelet glycoprotein Ib alpha chain, 850102595$compositionally biased region:Pro/Thr-rich, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850105822$glycosylation site:O-linked (GalNAc...), 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850116308$repeat:LRR 1, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
integrin-binding sialoprotein,BIOCARTA[30000209$h_npp1Pathway:Regulators of Bone Mineralization]
integrin-binding sialoprotein,INTERPRO[450007689$IPR008412:Bone sialoprotein II]
integrin-binding sialoprotein,KEGG_PATHWAY[470038853$hsa04510:Focal adhesion, 470038854$hsa04512:ECM-receptor interaction]
integrin-binding sialoprotein,PIR_SUPERFAMILY[630002693$PIRSF002579:bone sialoprotein]
integrin-binding sialoprotein,SP_PIR_KEYWORDS[790000183$biomineralization, 790000196$bone, 790000256$cell adhesion, 790000356$complete proteome, 790000445$direct protein sequencing, 790000616$glycoprotein, 790000744$hydroxyapatite binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001363$Secreted, 790001402$sialic acid, 790001403$sialoglycoprotein, 790001405$signal, 790001461$sulfation, 790001463$sulfoprotein]
integrin-binding sialoprotein,UP_SEQ_FEATURE[850008234$chain:Bone sialoprotein 2, 850102464$compositionally biased region:Asp/Glu-rich (acidic), 850102572$compositionally biased region:Poly-Glu, 850105770$glycosylation site:N-linked (GlcNAc...), 850105822$glycosylation site:O-linked (GalNAc...), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117335$short sequence motif:Cell attachment site, 850117814$signal peptide]
interleukin 17 receptor C,INTERPRO[450012192$IPR013568:SEFIR]
interleukin 17 receptor C,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000445$direct protein sequencing, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001405$signal, 790001555$transmembrane]
interleukin 17 receptor C,UP_SEQ_FEATURE[850026537$chain:Interleukin-17 receptor C, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
methyl-CpG binding domain protein 5,INTERPRO[450000267$IPR000313:PWWP, 450001542$IPR001739:Methyl-CpG DNA binding]
methyl-CpG binding domain protein 5,OMIM_DISEASE[520003159$Mental retardation, autosomal dominant 1]
methyl-CpG binding domain protein 5,SMART[760000264$SM00293:PWWP, 760000343$SM00391:MBD]
methyl-CpG binding domain protein 5,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000930$mental retardation, 790001065$nucleus, 790001212$polymorphism]
methyl-CpG binding domain protein 5,UP_SEQ_FEATURE[850031487$chain:Methyl-CpG-binding domain protein 5, 850102570$compositionally biased region:Poly-Gln, 850102581$compositionally biased region:Poly-Ser, 850102586$compositionally biased region:Pro-rich, 850104761$domain:MBD, 850105126$domain:PWWP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
nicotinate phosphoribosyltransferase domain containing 1,INTERPRO[450005827$IPR006405:Nicotinate phosphoribosyltransferase putative, 450014385$IPR015977:Nicotinate phosphoribosyltransferase-like]
nicotinate phosphoribosyltransferase domain containing 1,PIR_SUPERFAMILY[630000572$PIRSF000484:nicotinate phosphoribosyltransferase]
nicotinate phosphoribosyltransferase domain containing 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000619$glycosyltransferase, 790001162$phosphoprotein, 790001212$polymorphism, 790001282$pyridine nucleotide biosynthesis, 790001547$transferase]
nicotinate phosphoribosyltransferase domain containing 1,UP_SEQ_FEATURE[850034264$chain:Nicotinate phosphoribosyltransferase, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
protein tyrosine phosphatase, non-receptor type 20B; protein tyrosine phosphatase, non-receptor type 20A,INTERPRO[450000210$IPR000242:Protein-tyrosine phosphatase, receptor/non-receptor type, 450000330$IPR000387:Dual-specific/protein-tyrosine phosphatase, conserved region, 450000331$IPR000387:Protein-tyrosine phosphatase, 450014489$IPR016130:Protein-tyrosine phosphatase, active site]
protein tyrosine phosphatase, non-receptor type 20B; protein tyrosine phosphatase, non-receptor type 20A,SMART[760000168$SM00194:PTPc]
protein tyrosine phosphatase, non-receptor type 20B; protein tyrosine phosphatase, non-receptor type 20A,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790000960$microtubule, 790001065$nucleus, 790001162$phosphoprotein, 790001261$protein phosphatase, 790001301$receptor]
protein tyrosine phosphatase, non-receptor type 20B; protein tyrosine phosphatase, non-receptor type 20A,UP_SEQ_FEATURE[850000106$active site:Phosphocysteine intermediate, 850067653$chain:Tyrosine-protein phosphatase non-receptor type 20, 850105593$domain:Tyrosine-protein phosphatase, 850106258$modified residue, 850118574$splice variant]
ubiquitin-conjugating enzyme E2R 2,INTERPRO[450000520$IPR000608:Ubiquitin-conjugating enzyme, E2, 450014494$IPR016135:Ubiquitin-conjugating enzyme/RWD-like]
ubiquitin-conjugating enzyme E2R 2,KEGG_PATHWAY[470038837$hsa04120:Ubiquitin mediated proteolysis]
ubiquitin-conjugating enzyme E2R 2,SMART[760000185$SM00212:UBCc]
ubiquitin-conjugating enzyme E2R 2,SP_PIR_KEYWORDS[790000012$acetylation, 790000138$atp-binding, 790000356$complete proteome, 790000859$ligase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001593$ubl conjugation pathway]
ubiquitin-conjugating enzyme E2R 2,UP_SEQ_FEATURE[850000085$active site:Glycyl thioester intermediate, 850068100$chain:Ubiquitin-conjugating enzyme E2 R2, 850102464$compositionally biased region:Asp/Glu-rich (acidic), 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict]
urotensin 2 receptor,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450000572$IPR000670:Urotensin II receptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
urotensin 2 receptor,KEGG_PATHWAY[470038833$hsa04080:Neuroactive ligand-receptor interaction]
urotensin 2 receptor,PIR_SUPERFAMILY[630030079$PIRSF038575:urotensin II receptor, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
urotensin 2 receptor,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001546$transducer, 790001555$transmembrane]
urotensin 2 receptor,UP_SEQ_FEATURE[850099684$chain:Urotensin II receptor, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
zinc finger protein 280A,INTERPRO[450006475$IPR007087:Zinc finger, C2H2-type, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 280A,SMART[760000323$SM00355:ZnF_C2H2]
zinc finger protein 280A,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 280A,UP_SEQ_FEATURE[850101544$chain:Zinc finger protein 280A, 850117295$sequence variant, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4]
